Skip to main content
Top
Published in: European Journal of Nutrition 1/2022

01-02-2022 | Short Communication

Plant n-3 PUFA intake may lower the risk of atherosclerotic cardiovascular disease only among subjects with a low intake of marine n-3 PUFAs

Authors: Christian S. Bork, Søren Lundbye-Christensen, Stine K. Venø, Anne N. Lasota, Erik B. Schmidt, Kim Overvad

Published in: European Journal of Nutrition | Issue 1/2022

Login to get access

Abstract

The role of the major plant-derived n-3 PUFA, alpha-linolenic acid (ALA), on the risk of atherosclerotic cardiovascular (ASCVD) remains unclear, but most studies have reported no association. However, the association between intake of ALA and the risk of ASCVD may depend on the intake of marine n-3 PUFAs. We investigated this hypothesis among more than 53,909 middle-aged, Danish men and women followed for a median of 13.4 years. We found a statistically significant inverse association between ALA intake modelled as a restricted cubic spline and the rate of ASCVD in subjects with a low intake of marine n-3 PUFAs, while no association was observed among subjects with a higher intake of marine n-3 PUFAs. Our findings suggest that the intake of ALA may be associated with a lower risk of total ASCVD, but only among subjects with a low intake of marine n-3 PUFAs.
Literature
1.
go back to reference De Caterina R (2011) N-3 fatty acids in cardiovascular disease. N Engl J Med 364:2439–2450CrossRef De Caterina R (2011) N-3 fatty acids in cardiovascular disease. N Engl J Med 364:2439–2450CrossRef
3.
go back to reference Baker E, Miles E, Burdge G et al (2016) Metabolism and functional effects of plant-derived omega-3 fatty acids in humans. Prog Lipid Res 64:30–56CrossRef Baker E, Miles E, Burdge G et al (2016) Metabolism and functional effects of plant-derived omega-3 fatty acids in humans. Prog Lipid Res 64:30–56CrossRef
4.
go back to reference Rajaram S (2014) Health benefits of plant-derived alpha-linolenic acid. Am J Clin Nutr 100:443–448CrossRef Rajaram S (2014) Health benefits of plant-derived alpha-linolenic acid. Am J Clin Nutr 100:443–448CrossRef
5.
go back to reference de Lorgeril M, Salen P (2007) Mediterranean diet and n-3 fatty acids in the prevention and treatment of cardiovascular disease. J Cardiovasc Med 8:38–41CrossRef de Lorgeril M, Salen P (2007) Mediterranean diet and n-3 fatty acids in the prevention and treatment of cardiovascular disease. J Cardiovasc Med 8:38–41CrossRef
6.
go back to reference Mozaffarian D, Ascherio A, Hu F et al (2005) Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 111:157–164CrossRef Mozaffarian D, Ascherio A, Hu F et al (2005) Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation 111:157–164CrossRef
7.
go back to reference Tjønneland A, Olsen A, Boll K et al (2007) Study design, exposure variables, and socioeconomic determinants of participation in diet, cancer and health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35:432–441CrossRef Tjønneland A, Olsen A, Boll K et al (2007) Study design, exposure variables, and socioeconomic determinants of participation in diet, cancer and health: a population-based prospective cohort study of 57,053 men and women in Denmark. Scand J Public Health 35:432–441CrossRef
8.
go back to reference Tjønneland A, Overvad K, Haraldsdóttir J et al (1991) Validations of a semiquantative food frequency questionnaire developed in Denmark. Int J Epidemiol 20:906–912CrossRef Tjønneland A, Overvad K, Haraldsdóttir J et al (1991) Validations of a semiquantative food frequency questionnaire developed in Denmark. Int J Epidemiol 20:906–912CrossRef
Metadata
Title
Plant n-3 PUFA intake may lower the risk of atherosclerotic cardiovascular disease only among subjects with a low intake of marine n-3 PUFAs
Authors
Christian S. Bork
Søren Lundbye-Christensen
Stine K. Venø
Anne N. Lasota
Erik B. Schmidt
Kim Overvad
Publication date
01-02-2022
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nutrition / Issue 1/2022
Print ISSN: 1436-6207
Electronic ISSN: 1436-6215
DOI
https://doi.org/10.1007/s00394-021-02581-5

Other articles of this Issue 1/2022

European Journal of Nutrition 1/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine